Cyberonics Inc.
ORG
Cyberonics Inc. Cyberonics
The scientists at the Food and Drug Administration repeatedly and unanimously recommended rejecting the application of its maker, that is Cyberonics Inc., to sell it as such a treatment, said the report, written by the staff of the Senate Finance Committee. When some epilepsy patients reported that their moods had changed after receiving the devices, Cyberonics, based in Houston, implanted them in 235 depressed patients and turned the machines on in half of them. Cyberonics then turned the devices on in all 235 patients and determined that 30 percent showed significant improvement after six months or more.